0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Fertility after testicular cancer therapy?

Terra Ziporyn, PhD
JAMA. 1986;255(1):15-20. doi:10.1001/jama.1986.03370010017003.
Text Size: A A A
Published online

ABSTRACT

Today surgery, radiotherapy, and/or chemotherapy are saving the lives of many young men with testicular cancer. As life and death issues subside, however, a new worry arises: how will these treatments affect future fertility, particularly when sperm counts are low even before therapy?

Oncologists have long been concerned that radiotherapy or chemotherapy in particular might impair spermatogenesis or testosterone production. Results of small studies have suggested that certain patients may have impaired spermatogenic function even before antineoplastic treatment.

Results of larger studies presented at the International Congress of Andrology in Boston support this. According to Denmark's Jorgen G. Berthelsen, MD, the findings suggest that "in some cases a common genetic or environmental factor is responsible for both the impaired spermatogenesis and the predisposition to the development of cancer."

Information accumulating over the past two decades has indicated that most patients with unilateral testicular cancer have impaired semen quality before radiotherapy

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();